This report studies Alzheimer's Disease Drug in the Global market, especially in North America, China, Europe, Southeast Asia, Japan, and India, with production, revenue, consumption, import and export in these regions, from 2014 to 2019, and forecast to 2025.
Alzheimer's disease is a type of dementia that destroys memory and other important mental functions. No drug is available for curing the disease. Aricept, Exelon, Razadyne, and Namenda are some of the drugs used for reducing the symptoms of the disease.
The increasing prevalence of Alzheimer's disease is expected to propel the growth of the global Alzheimer's disease drug market. For instance, according to the data from the Alzheimer's Association, around 5.7 million people in the U.S. were suffering from Alzheimer’s disease in 2018. Moreover, increasing the geriatric population is also expected to aid in the growth of the market. For instance, according to the World Health Organization, the geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015.
Technological advancements in drug development are expected to boost the growth of the global Alzheimer's disease drug market. For instance, in April 2018, researchers from the University of Virginia School of Medicine reported the development of a new technique of accurately targeting molecules within cells to develop safer medicines, in the journal Neuron.
Opioid-based painkillers are often used in the treatment of Alzheimer's disease due to their ability to ease pain effectively. However, the use of opioid painkillers in Alzheimer's disease could cause severe side effects. This, in turn, is expected to hamper growth of the global Alzheimer's disease drug market.
R&D and the launch of a novel class of drugs are expected to offer lucrative growth opportunities for players in the global Alzheimer's disease drug market. For instance, in February 2020, ProteKt Therapeutics, a pharmaceutical startup based in Israel, announced its plans to develop a drug that targets an enzyme that is believed to a major cause of Alzheimer’s disease.
Major players in the market are focused on conducting clinical trials to expand their product portfolio. For instance, in February 2020, T3D Therapeutics, Inc. ("T3D" ), a clinical-stage drug developer based in the U.S., started screening and enrollment for the PIONEER Phase 2 clinical trial for its product candidate T3D-959 for the treatment of patients with mild to moderate Alzheimer's disease.
Key Takeaways:
✦ Increasing prevalence of Alzheimer's disease is expected to augment the growth of the global Alzheimer's disease drug market
✦ R&D and launch of a novel class of drugs is expected to offer lucrative growth opportunities for players in the market
✦ Major players operating in the global Alzheimer's disease drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, and Lundbeck
This report focuses on top manufacturers in the global market, with production, price, revenue, and market share for each manufacturer, covering
✑ Allergan
✑ Eisai
✑ Novartis
✑ Daiichi Sankyo
✑ Merz Pharma
✑ Pfizer
✑ Johnson & Johnson
✑ Lundbeck
...
On the basis of product, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into
✑ Donepezil
✑ Memantine
✑ Rivastigmine
By Application, the market can be split into
✑ Hospital Pharmacy
✑ Retail Pharmacy
✑ Online Pharmacy
By Regions, this report covers (we can add the regions/countries as you want)
✑ North America
✑ China
✑ Europe
✑ Southeast Asia
✑ Japan
✑ India
**NOTE: If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Alzheimer's Disease Drug Market Professional Survey Report 2019
1 Industry Overview of Alzheimer's Disease Drug
1.1 Definition and Specifications of Alzheimer's Disease Drug
1.1.1 Definition of Alzheimer's Disease Drug
1.1.2 Specifications of Alzheimer's Disease Drug
1.2 Classification of Alzheimer's Disease Drug
1.2.1 Donepezil
1.2.2 Memantine
1.2.3 Rivastigmine
1.3 Applications of Alzheimer's Disease Drug
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacy
1.3.3 Online Pharmacy
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Alzheimer's Disease Drug
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Alzheimer's Disease Drug
2.3 Manufacturing Process Analysis of Alzheimer's Disease Drug
2.4 Industry Chain Structure of Alzheimer's Disease Drug
3 Technical Data and Manufacturing Plants Analysis of Alzheimer's Disease Drug
3.1 Capacity and Commercial Production Date of Global Alzheimer's Disease Drug Major Manufacturers in 2018
3.2 Manufacturing Plants Distribution of Global Alzheimer's Disease Drug Major Manufacturers in 2018
3.3 R&D Status and Technology Source of Global Alzheimer's Disease Drug Major Manufacturers in 2018
3.4 Raw Materials Sources Analysis of Global Alzheimer's Disease Drug Major Manufacturers in 2018
4 Global Alzheimer's Disease Drug Overall Market Overview
4.1 2014-2019E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2014-2019E Global Alzheimer's Disease Drug Capacity and Growth Rate Analysis
4.2.2 2018 Alzheimer's Disease Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2014-2019E Global Alzheimer's Disease Drug Sales and Growth Rate Analysis
4.3.2 2018 Alzheimer's Disease Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2014-2019E Global Alzheimer's Disease Drug Sales Price
4.4.2 2018 Alzheimer's Disease Drug Sales Price Analysis (Company Segment)
5 Alzheimer's Disease Drug Regional Market Analysis
5.1 North America Alzheimer's Disease Drug Market Analysis
5.1.1 North America Alzheimer's Disease Drug Market Overview
5.1.2 North America 2014-2019E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2014-2019E Alzheimer's Disease Drug Sales Price Analysis
5.1.4 North America 2018 Alzheimer's Disease Drug Market Share Analysis
5.2 China Alzheimer's Disease Drug Market Analysis
5.2.1 China Alzheimer's Disease Drug Market Overview
5.2.2 China 2014-2019E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2014-2019E Alzheimer's Disease Drug Sales Price Analysis
5.2.4 China 2018 Alzheimer's Disease Drug Market Share Analysis
5.3 Europe Alzheimer's Disease Drug Market Analysis
5.3.1 Europe Alzheimer's Disease Drug Market Overview
5.3.2 Europe 2014-2019E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2014-2019E Alzheimer's Disease Drug Sales Price Analysis
5.3.4 Europe 2018 Alzheimer's Disease Drug Market Share Analysis
5.4 Southeast Asia Alzheimer's Disease Drug Market Analysis
5.4.1 Southeast Asia Alzheimer's Disease Drug Market Overview
5.4.2 Southeast Asia 2014-2019E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2014-2019E Alzheimer's Disease Drug Sales Price Analysis
5.4.4 Southeast Asia 2018 Alzheimer's Disease Drug Market Share Analysis
5.5 Japan Alzheimer's Disease Drug Market Analysis
5.5.1 Japan Alzheimer's Disease Drug Market Overview
5.5.2 Japan 2014-2019E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2014-2019E Alzheimer's Disease Drug Sales Price Analysis
5.5.4 Japan 2018 Alzheimer's Disease Drug Market Share Analysis
5.6 India Alzheimer's Disease Drug Market Analysis
5.6.1 India Alzheimer's Disease Drug Market Overview
5.6.2 India 2014-2019E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2014-2019E Alzheimer's Disease Drug Sales Price Analysis
5.6.4 India 2018 Alzheimer's Disease Drug Market Share Analysis
6 Global 2014-2019E Alzheimer's Disease Drug Segment Market Analysis (by Type)
6.1 Global 2014-2019E Alzheimer's Disease Drug Sales by Type
6.2 Different Types of Alzheimer's Disease Drug Product Interview Price Analysis
6.3 Different Types of Alzheimer's Disease Drug Product Driving Factors Analysis
6.3.1 Donepezil of Alzheimer's Disease Drug Growth Driving Factor Analysis
6.3.2 Memantine of Alzheimer's Disease Drug Growth Driving Factor Analysis
6.3.3 Rivastigmine of Alzheimer's Disease Drug Growth Driving Factor Analysis
7 Global 2014-2019E Alzheimer's Disease Drug Segment Market Analysis (by Application)
7.1 Global 2014-2019E Alzheimer's Disease Drug Consumption by Application
7.2 Different Application of Alzheimer's Disease Drug Product Interview Price Analysis
7.3 Different Application of Alzheimer's Disease Drug Product Driving Factors Analysis
7.3.1 Hospital Pharmacy of Alzheimer's Disease Drug Growth Driving Factor Analysis
7.3.2 Retail Pharmacy of Alzheimer's Disease Drug Growth Driving Factor Analysis
7.3.3 Online Pharmacy of Alzheimer's Disease Drug Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Alzheimer's Disease Drug
8.1 Allergan
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Allergan 2018 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Allergan 2018 Alzheimer's Disease Drug Business Region Distribution Analysis
8.2 Eisai
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Eisai 2018 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Eisai 2018 Alzheimer's Disease Drug Business Region Distribution Analysis
8.3 Novartis
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Novartis 2018 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Novartis 2018 Alzheimer's Disease Drug Business Region Distribution Analysis
8.4 Daiichi Sankyo
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Daiichi Sankyo 2018 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Daiichi Sankyo 2018 Alzheimer's Disease Drug Business Region Distribution Analysis
8.5 Merz Pharma
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Merz Pharma 2018 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Merz Pharma 2018 Alzheimer's Disease Drug Business Region Distribution Analysis
8.6 Pfizer
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Pfizer 2018 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Pfizer 2018 Alzheimer's Disease Drug Business Region Distribution Analysis
8.7 Johnson & Johnson
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Johnson & Johnson 2018 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Johnson & Johnson 2018 Alzheimer's Disease Drug Business Region Distribution Analysis
8.8 Lundbeck.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Lundbeck. 2018 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Lundbeck. 2018 Alzheimer's Disease Drug Business Region Distribution Analysis
9 Development Trend of Analysis of Alzheimer's Disease Drug Market
9.1 Global Alzheimer's Disease Drug Market Trend Analysis
9.1.1 Global 2019-2022 Alzheimer's Disease Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2019-2022 Alzheimer's Disease Drug Sales Price Forecast
9.2 Alzheimer's Disease Drug Regional Market Trend
9.2.1 North America 2019-2022 Alzheimer's Disease Drug Consumption Forecast
9.2.2 China 2019-2022 Alzheimer's Disease Drug Consumption Forecast
9.2.3 Europe 2019-2022 Alzheimer's Disease Drug Consumption Forecast
9.2.4 Southeast Asia 2019-2022 Alzheimer's Disease Drug Consumption Forecast
9.2.5 Japan 2019-2022 Alzheimer's Disease Drug Consumption Forecast
9.2.6 India 2019-2022 Alzheimer's Disease Drug Consumption Forecast
9.3 Alzheimer's Disease Drug Market Trend (Product Type)
9.4 Alzheimer's Disease Drug Market Trend (Application)
10 Alzheimer's Disease Drug Marketing Type Analysis
10.1 Alzheimer's Disease Drug Regional Marketing Type Analysis
10.2 Alzheimer's Disease Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Alzheimer's Disease Drug by Region
10.4 Alzheimer's Disease Drug Supply Chain Analysis
11 Consumers Analysis of Alzheimer's Disease Drug
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Alzheimer's Disease Drug Market Professional Survey Report 2019
Methodology
Analyst Introduction
Data Source
Request Discount 
Inquire Before Buy
